The role of diffusion weighted imaging in magnetic resonance to evaluate breast masses
Yıl: 2020 Cilt: 3 Sayı: 1 Sayfa Aralığı: 37 - 46 Metin Dili: İngilizce DOI: 10.30714/j-ebr.2020157452 İndeks Tarihi: 22-11-2020
The role of diffusion weighted imaging in magnetic resonance to evaluate breast masses
Öz: Aim: To investigate the role of diffusion weighted magnetic resonance imaging (MRI) indifferentiation of benign and malignant breast lesions using apparent diffusion coefficient (ADC)values preoperatively.Methods: A total of 30 women between the ages of 14-75 years (mean, 47, 6 years) with 30histopathologically verified breast lesions were investigated in this study. The patients were examinedby a 1 , 5 T MRI device using bilateral phased array breast coil. Spin echo planar diffusion imagingwas used to scan patients. Images were obtained by b values 0 and 500 seconds/mm². Mean ADCvalues of the benign and malignant lesions were measured and calculated. The comparison betweenthe histopathological diagnoses and the mean ADCs were performed by Mann Whitney U test.Results: The diagnosis of 30 patients with 30 breast lesions were as follows; malign lesions (n=13),benign lesions (n=17). The ADC values were as follows (in units of 10-3mm² /sec): benign breastlesions (range: 1, 09-1, 98, mean: 1 , 45) and malignant breast lesions (range: 0, 59-1, 08, mean: 0,76). The mean ADC obtained from malignant breast lesions was statistically different from thatobserved in benign solid lesions (p<0, 01).Conclusion: Diffusion imaging can be used in differentiation of malign and benign breast lesions.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- [1]Ferlay J, Soerjomataram I, Dikshit R. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):359–86.
- [2]Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-917.
- [3]Kopans DB. The positive predictive value of mammography. AJR Am J Roentgenol. 1992;158(3):521-26.
- [4]Aberle DR, Chiles C, Gatsonis C, et al. Imaging and cancer: research strategy of the American College of Radiology Imaging Network. Radiology. 2005;235(3):741-51.
- [5]Leung JW. Screening mammography reduces morbidity of breast cancer treatment. AJR Am J Roentgenol. 2005;184(5):1508-09.
- [6]Mahesh M. AAPM/RSNA physics tutorial for residents: digital mammography: an overview. Radiographics. 2004;24(6):1747- 60.
- [7]Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology. 2001, 220(1): 13-30.
- [8]Kuhl CK, Mielcareck P, Klaschik S, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?. Radiology. 1999;211(1): 101-10.
- [9]Partridge SC, DeMartini WB, Kurland BF, et al. Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value. AJR Am J Roentgenol. 2009;193(6):1716- 22.
- [10] Hetta W. Role of diffusion weighted images combined with breast MRI in improving the detection and differentiation of breast lesions. Egypt J Radiol Nucl Med. 2015; 46 (1): 259-70.
- [11] Sinha S, Lucas-Quesada FA, Sinha U, et al. In vivo diffusion-weighted MRI of the breast: potential for lesion characterization. J Magn Reson Imaging. 2002;15(6):693– 704.
- [12] Provenzale JM, Sorensen AG. Diffusionweighted MR imaging in acute stroke: theoretic considerations and clinical applications. AJR 1999; 173(6): 1459– 67.
- [13] Le Bihan D, Breton E, Lallemand D, et al. Separation of diffusion and perfusion in intra-voxel incoherent motion imaging. Radiology. 1988;168(2): 497–505.
- [14] Guo Y, Cai ZI, Cai YQ, et al. Elementary Clinical Estimation of DWI and ADC Value in Differentiating Benign and Malignant Breast Lesions [abstract]. In: Proceedings of the Eighth Annual Meeting of ISRMRM, Denver, 2000:2158. Proc Intl Sot Mag Reson Med. 2000; 8:2158.
- [15] Van Bodegraven EA, van Raaij JC, Van Goethem M, et al. Guidelines and recommendations for MRI in breast cancer follow-up: A review. Eur J Obstet Gynecol Reprod Biol. 2017;218:5–11.
- [16] Mehnati P, Tirtash MJ. Comparative efficacy of four imaging instruments for breast cancer screening. Asian Pac J Cancer Prev. 2015;16(15):6177–86.
- [17] Robinson IA, McKee G, Nicholson A, et al. Prognostic value of cytological grading of fine-needle aspirates from breast carcinomas. Lancet. 1999; 343(8903):947- 49.
- [18] Ducatman BS, Emery ST, Wang HH. Correlation of histologic grade of breast carcinoma with cytologic features on fineneedle aspiration of the breast. Mod Pathol. 1993;6(5):539–43.
- [19] Le Bihan D, Breton E, Lallemand D, et al. MR Imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology. 1986;161(2): 401 -7.
- [20] Yamashita Y, Tang Y, Takahashi M. Ultrafast MR imaging of the abdomen: echo planar imaging and diffusion-weighted imaging. J Magn Reson Imaging. 1998;8(2):367–74.
- [21] Kinoshita T, Yashiro N, Ihara N, et al. Diffusion weighted half-Fourier single-shot turbo spin echo imaging in breast tumors: differentiation of invasive ductal carcinoma from fibroadenoma. J Comput Assist Tomogr. 2002;26(6):1042-46.
- [22] Guo Y, Cai YQ, Cai ZL, et al. Differentiation of clinically benign and malignant breast lesions using diffusion weighted imaging. J Magn Reson Imaging. 2002;16(2):172-78.
- [23] Sugahara T, Korogi Y, Kochi M, et al. Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging. 1999; 9(1): 53–60.
- [24] Marini C, Facconi C, Giannelli M, et al. Quantitative diffusion-weighted MR imaging in the differantial diagnosis of breast lesion. Eur Radiol. 2007; 17(10):2646-55.
- [25] Partridge SC, Demartini WB, Kurland BF, et al. Differantial diagnosis of mammographically and clinically occult breast lesions on diffusion-weighted MRI. J Magn Reson Imaging. 2010;31(3);562-70.
- [26] Buadu LD, Murakami J, Murayama S, et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology. 1996; 200(3):639–49.
- [27] Von Dijke CF, Brasch RC, Roberts TP, et al. Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density. Radiology. 1996;198(3):813–18.
- [28] Kuroki Y, Nasu K, Kuroki S, Murakami K, et al. Diffusion-weighted imaging of breast cancer with the sensitivity encoding technique: analysis of the apparent diffusion coefficient value. Magn Reson Med Sci. 2004;3(2):79-85.
- [29] Woodhams R, Matsunaga K, Iwabuchi K, et al. Diffusion-weighted imaging of malignant breast tumors: the usefulness of apparent diffusion coefficient (ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension. J Comput Assist Tomogr. 2005; 29(5): 644– 49.
- [30] Partridge SC, McKinnon GC, Henry RG, etal. Menstrual Cycle Variation of Apparent Diffusion Coefficients Measured in the Normal Breast Using MRI. J Magn Reson Imaging. 2001;14(4):433-38.
APA | OZBALCI A, Öztürk E, YÜCESOY C, Özbalcı G, Seker G (2020). The role of diffusion weighted imaging in magnetic resonance to evaluate breast masses. , 37 - 46. 10.30714/j-ebr.2020157452 |
Chicago | OZBALCI AYSU BASAK,Öztürk Emine,YÜCESOY CÜNEYT,Özbalcı Gökhan Selçuk,Seker Gaye Ebru The role of diffusion weighted imaging in magnetic resonance to evaluate breast masses. (2020): 37 - 46. 10.30714/j-ebr.2020157452 |
MLA | OZBALCI AYSU BASAK,Öztürk Emine,YÜCESOY CÜNEYT,Özbalcı Gökhan Selçuk,Seker Gaye Ebru The role of diffusion weighted imaging in magnetic resonance to evaluate breast masses. , 2020, ss.37 - 46. 10.30714/j-ebr.2020157452 |
AMA | OZBALCI A,Öztürk E,YÜCESOY C,Özbalcı G,Seker G The role of diffusion weighted imaging in magnetic resonance to evaluate breast masses. . 2020; 37 - 46. 10.30714/j-ebr.2020157452 |
Vancouver | OZBALCI A,Öztürk E,YÜCESOY C,Özbalcı G,Seker G The role of diffusion weighted imaging in magnetic resonance to evaluate breast masses. . 2020; 37 - 46. 10.30714/j-ebr.2020157452 |
IEEE | OZBALCI A,Öztürk E,YÜCESOY C,Özbalcı G,Seker G "The role of diffusion weighted imaging in magnetic resonance to evaluate breast masses." , ss.37 - 46, 2020. 10.30714/j-ebr.2020157452 |
ISNAD | OZBALCI, AYSU BASAK vd. "The role of diffusion weighted imaging in magnetic resonance to evaluate breast masses". (2020), 37-46. https://doi.org/10.30714/j-ebr.2020157452 |
APA | OZBALCI A, Öztürk E, YÜCESOY C, Özbalcı G, Seker G (2020). The role of diffusion weighted imaging in magnetic resonance to evaluate breast masses. Experimental Biomedical Research, 3(1), 37 - 46. 10.30714/j-ebr.2020157452 |
Chicago | OZBALCI AYSU BASAK,Öztürk Emine,YÜCESOY CÜNEYT,Özbalcı Gökhan Selçuk,Seker Gaye Ebru The role of diffusion weighted imaging in magnetic resonance to evaluate breast masses. Experimental Biomedical Research 3, no.1 (2020): 37 - 46. 10.30714/j-ebr.2020157452 |
MLA | OZBALCI AYSU BASAK,Öztürk Emine,YÜCESOY CÜNEYT,Özbalcı Gökhan Selçuk,Seker Gaye Ebru The role of diffusion weighted imaging in magnetic resonance to evaluate breast masses. Experimental Biomedical Research, vol.3, no.1, 2020, ss.37 - 46. 10.30714/j-ebr.2020157452 |
AMA | OZBALCI A,Öztürk E,YÜCESOY C,Özbalcı G,Seker G The role of diffusion weighted imaging in magnetic resonance to evaluate breast masses. Experimental Biomedical Research. 2020; 3(1): 37 - 46. 10.30714/j-ebr.2020157452 |
Vancouver | OZBALCI A,Öztürk E,YÜCESOY C,Özbalcı G,Seker G The role of diffusion weighted imaging in magnetic resonance to evaluate breast masses. Experimental Biomedical Research. 2020; 3(1): 37 - 46. 10.30714/j-ebr.2020157452 |
IEEE | OZBALCI A,Öztürk E,YÜCESOY C,Özbalcı G,Seker G "The role of diffusion weighted imaging in magnetic resonance to evaluate breast masses." Experimental Biomedical Research, 3, ss.37 - 46, 2020. 10.30714/j-ebr.2020157452 |
ISNAD | OZBALCI, AYSU BASAK vd. "The role of diffusion weighted imaging in magnetic resonance to evaluate breast masses". Experimental Biomedical Research 3/1 (2020), 37-46. https://doi.org/10.30714/j-ebr.2020157452 |